Article

Index Provides New Insights into Lupus Cardiac Risks

The heart rate recovery (HRR) index is deteriorated in persons who have systemic lupus erythematosus (SLE).

The heart rate recovery (HRR) index is deteriorated in persons who have systemic lupus erythematosus (SLE). This index is a simple measure that may be clinically useful for identifying patients with SLE who are at high risk for cardiac disease.

In this study-perhaps the only one to examine the HRR index in persons with SLE-Dogdu and coworkers tested cardiac function (electrocardiography, echocardiography, treadmill exercise) in 48 patients and 44 controls. They defined the HRR index as the reduction in heart rate from peak exercise to the first, second, third, and fifth minutes (HRR1, HRR2, HRR3, HRR5) of exercise recovery.

The SLE and control groups did not differ in baseline echocardiographic values: left ventricular (LV) diameter, ejection fraction, LV mass, right ventricular diastolic diameter, and pulmonary artery systolic pressure. However, differences emerged during stress testing. HRR1 and HRR2 indices were significantly lower in persons with SLE than in controls. The same was true for HRR3 and HRR5 during exercise recovery. Metabolic equivalents during exercise testing were significantly lower in persons with SLE.

The authors noted that when the prognostic significance of the HRR index is considered, these results may explain the increased occurrence of cardiac death in patients with SLE.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.